These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 15905710)
21. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Clemett D; Markham A Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042 [TBL] [Abstract][Full Text] [Related]
27. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease. Rutgeerts P Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886 [No Abstract] [Full Text] [Related]
29. Current treatment for prevention of relapse and recurrence in Crohn's disease. Prantera C; Scribano ML Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572 [TBL] [Abstract][Full Text] [Related]
30. Mesalazine as a maintenance treatment in Crohn's disease. Sutherland LR; Steinhart AH Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902 [No Abstract] [Full Text] [Related]
31. Medical therapy to reduce postoperative Crohn's disease recurrence. Achkar JP; Hanauer SB Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318 [TBL] [Abstract][Full Text] [Related]
32. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions]. Uittenbogaart SB; Klemt-Kropp M Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease. Akobeng AK Am J Gastroenterol; 2011 Oct; 106(10):1857; author reply 1857-8. PubMed ID: 21979212 [No Abstract] [Full Text] [Related]
34. Obstructing Crohn's disease of the duodenum: is surgery always mandatory? Karaoglu AO; Yukselen V Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874 [TBL] [Abstract][Full Text] [Related]
35. Mesalazine for the treatment of inflammatory bowel disease. Criscuoli V; Modesto I; Orlando A; Cottone M Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798 [TBL] [Abstract][Full Text] [Related]
36. Update on the management of Crohn's disease. Buchner AM; Blonski W; Lichtenstein GR Curr Gastroenterol Rep; 2011 Oct; 13(5):465-74. PubMed ID: 21792543 [TBL] [Abstract][Full Text] [Related]
37. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease]. Moum B Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043 [TBL] [Abstract][Full Text] [Related]
38. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery. Doherty G; Moss AC Am J Gastroenterol; 2012 Mar; 107(3):487; author reply 487-8. PubMed ID: 22388032 [No Abstract] [Full Text] [Related]
39. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504 [TBL] [Abstract][Full Text] [Related]
40. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Cammà C; Giunta M; Rosselli M; Cottone M Gastroenterology; 1997 Nov; 113(5):1465-73. PubMed ID: 9352848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]